Efficacy and Safety of Cetuximab in Combination With Cisplatin Gemcitabine as First-Line Therapy in Advanced NSCLC
Clinical trial NCT00561054 · UNKNOWN
Trial details
- NCT number
- NCT00561054
- Sponsor
- Grupo Portugues de Estudo do Cancro do Pulmao
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.